Spinout Gnosis Health has raised £1.1m to support the development and launch of its AI-powered digital healthcare assistant MAXine, which is designed to transform the management of Parkinson’s disease.
Gnosis Health is a spinout of the universities of Newcastle and Plymouth and has created the MAXine healthcare assistant in response to an urgent clinical need.
Integrating data from wearables, patient-reported outcomes and behavioural patterns, MAXine provides real-time insights to patients and clinicians, and offers continuous, adaptive monitoring that enhances self-management and improves care team communication.
Affecting more than 153,000 people in the UK, Gnosis Health says those living with Parkinson’s typically receive only 30 minutes of clinician time per year. Symptoms fluctuate, requiring consistent monitoring, and existing approaches rely largely on questionnaires or infrequent clinical observation, resulting in fragmented care.
MAXine strives to bridge this gap, capturing symptom changes throughout the day and generating actionable insights.
The funding round includes a £550,000 Innovate UK investor partnership grant and further investment from SFC Capital and Northstar Ventures.
The funds will enable Gnosis to complete its North East NHS pilots, scale the engineering team, and prepare MAXine for its commercial debut.
“Our universities are renowned for producing spinout companies that have global potential,” says Will Cousins, investment manager at Northstar Ventures. “Gnosis Health is tackling one of the most pressing challenges in chronic disease management.
“MAXine represents a step change in remote monitoring for Parkinson’s, combining clinical rigour with cutting edge AI to deliver meaningful value to patients and care teams alike.”
